Evidence map›Paper›PMID 27056980›Full record

ArticleHuman molecular genetics2016

Mutations and altered expression of SERPINF1 in patients with familial otosclerosis.

Joanna L Ziff, Michael Crompton, Harry R F Powell, Jeremy A Lavy, Christopher P Aldren, Karen P Steel, Shakeel R Saeed, Sally J Dawson

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Heterozygous Nonsense Mutation in the Nuclear Transport FactorInternational journal of molecular sciences · 2026
    Article
  5. Exploring the genetic landscape of otosclerosis: current understanding and future perspectives.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2025
    Review
  6. Review
  7. Journal of medical genetics · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Cartilage · 2021
    Article
  17. Article
  18. Insufficient evidence for a role of SERPINF1 in otosclerosis.Molecular genetics and genomics : MGG · 2019
    Article
  19. The CaBone · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Joanna L ZiffUCL Ear Institute, University College London, London WC1X 8EE, UK.
Michael CromptonUCL Ear Institute, University College London, London WC1X 8EE, UK.
Harry R F PowellRoyal National Throat Nose and Ear Hospital, London WC1X 8EE, UK.
Jeremy A LavyRoyal National Throat Nose and Ear Hospital, London WC1X 8EE, UK.
Christopher P AldrenDepartment of ENT Surgery, The Princess Margaret Hospital, Windsor SL4 3SJ, UK.
Karen P SteelWellcome Trust Sanger Institute, Hinxton CB10 1SA.
Shakeel R SaeedUCL Ear Institute, University College London, London WC1X 8EE, UK.
Sally J DawsonUCL Ear Institute, University College London, London WC1X 8EE, UK, sally.dawson@ucl.ac.uk
University College London · GBRoyal National Throat Nose and Ear Hospital · GBBMI The Princess Margaret Hospital · GBEnergy Institute · GBWellcome Sanger Institute · GB

Funding

Medical Research Council G0300212Medical Research Council MC_QA137918Medical Research Council MR/N012119/1Wellcome Trust
6 · The paper itself

Abstract

Otosclerosis is a relatively common heterogenous condition, characterized by abnormal bone remodelling in the otic capsule leading to fixation of the stapedial footplate and an associated conductive hearing loss. Although familial linkage and candidate gene association studies have been performed in recent years, little progress has been made in identifying disease-causing genes. Here, we used whole-exome sequencing in four families exhibiting dominantly inherited otosclerosis to identify 23 candidate variants (reduced to 9 after segregation analysis) for further investigation in a secondary cohort of 84 familial cases. Multiple mutations were found in the SERPINF1 (Serpin Peptidase Inhibitor, Clade F) gene which encodes PEDF (pigment epithelium-derived factor), a potent inhibitor of angiogenesis and known regulator of bone density. Six rare heterozygous SERPINF1 variants were found in seven patients in our familial otosclerosis cohort; three are missense mutations predicted to be deleterious to protein function. The other three variants are all located in the 5'-untranslated region (UTR) of an alternative spliced transcript SERPINF1-012 RNA-seq analysis demonstrated that this is the major SERPINF1 transcript in human stapes bone. Analysis of stapes from two patients with the 5'-UTR mutations showed that they had reduced expression of SERPINF1-012 All three 5'-UTR mutations are predicted to occur within transcription factor binding sites and reporter gene assays confirmed that they affect gene expression levels. Furthermore, RT-qPCR analysis of stapes bone cDNA showed that SERPINF1-012 expression is reduced in otosclerosis patients with and without SERPINF1 mutations, suggesting that it may be a common pathogenic pathway in the disease.

Indexed as

Genetic Predisposition to DiseaseBone DensityBone RemodelingExomeEye ProteinsFemaleGene Expression RegulationHeterozygoteHumansMaleMutationNerve Growth FactorsOtosclerosisPedigreePigment Epithelium-Derived FactorSequence Analysis, DNAEye ProteinsNerve Growth FactorsPigment Epithelium-Derived FactorSerpins

Identifiers

PMID27056980
PMCPMC5181625
OpenAlexW2342263973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.